BACKGROUND: Uncertainties remain about the role of serotonin in the aetiology and treatment of panic disorder. AIMS: To investigate the effect of reducing brain serotonin function on anxiety at rest, and following 5% CO2 provocation in normal controls and patients with panic disorder. METHOD: Twenty drug-free patients with DSM-III-R panic disorder and 19 controls received atryptophan-free amino acid drink on one occasion and a control drink on the other in a double-blind, balanced protocol. 5% CO2 was given as a panic challenge after 270 minutes. RESULTS:Plasma tryptophan fell by more than 80% both patients and controls after the tryptophan-free drink. Tryptophan depletion did not alter resting anxiety. In patients alone, tryptophan depletion caused a greater anxiogenic response and an increased rate of panic attacks (9 v. 2, P < 0.05) after 5% CO2 challenge. No normal volunteers panicked. CONCLUSIONS:Serotonin may directly modulate panic anxiety in patients with panic disorder. This may underlie the efficacy of serotonergic antidepressants in treating panic disorder.
RCT Entities:
BACKGROUND: Uncertainties remain about the role of serotonin in the aetiology and treatment of panic disorder. AIMS: To investigate the effect of reducing brain serotonin function on anxiety at rest, and following 5% CO2 provocation in normal controls and patients with panic disorder. METHOD: Twenty drug-free patients with DSM-III-R panic disorder and 19 controls received a tryptophan-free amino acid drink on one occasion and a control drink on the other in a double-blind, balanced protocol. 5% CO2 was given as a panic challenge after 270 minutes. RESULTS: Plasma tryptophan fell by more than 80% both patients and controls after the tryptophan-free drink. Tryptophan depletion did not alter resting anxiety. In patients alone, tryptophan depletion caused a greater anxiogenic response and an increased rate of panic attacks (9 v. 2, P < 0.05) after 5% CO2 challenge. No normal volunteers panicked. CONCLUSIONS:Serotonin may directly modulate panic anxiety in patients with panic disorder. This may underlie the efficacy of serotonergic antidepressants in treating panic disorder.
Authors: Abigail A Marsh; Elizabeth C Finger; Beata Buzas; Niveen Soliman; Rebecca A Richell; Meena Vythilingham; Daniel S Pine; David Goldman; R J R Blair Journal: Psychopharmacology (Berl) Date: 2006-09-30 Impact factor: 4.530
Authors: Nabeel Nabulsi; Yiyun Huang; David Weinzimmer; Jim Ropchan; James J Frost; Timothy McCarthy; Richard E Carson; Yu-Shin Ding Journal: Nucl Med Biol Date: 2009-12-01 Impact factor: 2.408
Authors: Caroline Bell; Sean Hood; John Potokar; Jon Nash; Mariona Adrover; Chris Frampton; Dana Hince; Ann Rich; Spilios Argyropoulos; David Nutt Journal: Psychopharmacology (Berl) Date: 2009-10-13 Impact factor: 4.530
Authors: Dawn M Richard; Michael A Dawes; Charles W Mathias; Ashley Acheson; Nathalie Hill-Kapturczak; Donald M Dougherty Journal: Int J Tryptophan Res Date: 2009-03-23